Correlation Between Idiopathic Parkinson's Disease and Diabetes Mellitus
NCT ID: NCT03685357
Last Updated: 2018-09-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
120 participants
OBSERVATIONAL
2018-07-01
2020-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Clinical Profile of Parkinson Disease in Egypt
NCT03383497
Comparison Between Parkinson's Disease and Parkinson's Dementia Complex (Genetically,Clinical and Electrophysiological)
NCT05759403
Clinical Profile of Parkinson's Disease in Patients With Hepatitis C Infection
NCT03420573
Determining Clinical Profile of Parkinson's Disease Among Egyptian Population
NCT02785510
Predictors of Parkinson's Disease Progression
NCT04062279
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. Oral glucose tolerance test will be performed and compared between Group 3 and Group 4.
3. Association between glucose level and motor complication of L-dopa among Idiopathic Parkinson's patients using Unified Parkinson's Disease Rating Scale (UDPRS).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Idiopathic Parkinson's
Oral glucose tolerance test
The Unified Parkinson's Disease Rating Scale (UDPRS).
No interventions assigned to this group
Diabetics receive sulphonylurea group
Record RBDSQ ("Rapid eye movement Sleep" Behavior Disorder Screening Questionnaire) total score
No interventions assigned to this group
Diabetics on sulphonylurea and metformin
Record RBDSQ ("Rapid eye movement Sleep" Behavior Disorder Screening Questionnaire) total score
No interventions assigned to this group
Healthy
Record RBDSQ ("Rapid eye movement Sleep" Behavior Disorder Screening Questionnaire) total score
Oral glucose tolerance test
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Idiopathic Parkinsonism
Exclusion Criteria
2. Drug induced Parkinsonism.
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Al-Azhar University
OTHER
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Afnan Awad-Allah Elgnainy
Master student, teaching assistant of Clinical Pharmacy
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Afnan Elgnainy
Role: PRINCIPAL_INVESTIGATOR
AinShams University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AinShams University
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
AwadAllah Elgnainy A, Hamed MI, Osman Mohamed W, Sabri NA. Investigation of the Possible Correlation between Idiopathic Parkinson's Disease and Diabetes Mellitus in Egyptian Patients: A Pilot Study. Neurol Res Int. 2021 Nov 12;2021:2838669. doi: 10.1155/2021/2838669. eCollection 2021.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AinShamsUni Afnan
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.